whole exome sequencing (wes)

What are the Limitations of WES in Cancer?

While WES is a powerful tool, it has several limitations:
1. Non-Coding Regions: WES does not capture mutations in non-coding regions of the genome, which can also play a role in cancer.
2. Structural Variants: WES may miss large structural variants and copy number variations that are detected more easily with WGS.
3. Coverage Gaps: Some exonic regions may not be well-covered due to technical limitations, potentially missing important mutations.

Frequently asked queries:

Partnered Content Networks

Relevant Topics